M&A advisory across the post-acute and behavioral health continuum — from home health and hospice to behavioral platforms and ABA therapy.
Skilled nursing and therapy at home — recurring revenue with favorable demographic tailwinds.
End-of-life care with predictable per-diem reimbursement and strong operator economics at scale.
Short-term rehab and long-term care — selective assets remain attractive amid regulatory shifts.
High-acuity rehab driven by aging demographics and complex procedure growth.
One of the fastest-growing post-acute segments with strong commercial reimbursement.
Acute stabilization with high barriers-to-entry and limited bed supply versus demand.
24-hour supervised SUD, eating-disorder, and mental health care with strong outcomes data.
The fastest-growing modality in behavioral health investment, with strong commercial reimbursement.
Highly fragmented, low capital intensity, with growing telehealth penetration.
Medicaid-funded ABA with predictable revenue — among the most defensible streams in healthcare services.
Consolidation dynamics, reimbursement trends, and PE / strategic activity across home health, hospice, SNFs, IRFs, infusion, behavioral platforms, and IDD/ABA services.